New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial
Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both
Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both
TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that
TB Alliance, an international non-profit that develops better, faster-acting, and affordable tuberculosis (TB) drugs, announced today the establishment of an
TB Alliance today announced the launch of its new web portal (www.tballiance.org/children) which seeks to bridge an information gap that
New York, USA: TB Alliance has received a grant from the United Kingdom’s Department for International Development (DFID) to support
New York, USA: The Global Alliance for TB Drug Development (TB Alliance) has received a grant from the Australian Agency
The Global Health Innovative Technology Fund (GHIT Fund), a new public-private partnership that’s bringing Japanese research and development (R&D) to
In spite of an estimated 500,000 new annual cases of children with tuberculosis (TB), there are no appropriate medicines for
TB Alliance, a not-for-profit organization with the mission of developing new, improved, and affordable TB treatments, announces the election of
The Global Alliance for TB Drug Development (TB Alliance) is pleased to announce the appointment of Dr. Carlos Morel to